Defining conditions for the co-culture of Caco-2 and HT29-MTX cells using Taguchi design

Journal of Pharmacological and Toxicological Methods

Volumn 61, Issue 3, 2010, Pages 334-342

  Chen, Xiu Min ^a   Elisia, Ingrid ^a   Kitts, David D ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Drug permeability; Inflammation; Nitric oxide; Paracellular transport; Small intestine; Transcellular transport

Indexed keywords

FUROSEMIDE; KETOPROFEN; NITRIC OXIDE; PROPRANOLOL;

ACCURACY; ARTICLE; CELL CULTURE; CELL STRAIN CACO 2; CELL STRAIN HT29; COCULTURE; CONTROLLED STUDY; CULTURE MEDIUM; CULTURE OPTIMIZATION; DRUG PENETRATION; ENTERITIS; EXPERIMENTAL DESIGN; GOBLET CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; INTESTINE CELL; MONOLAYER CULTURE; REPRODUCIBILITY; SMALL INTESTINE; TRANSCYTOSIS;

CACO-2 CELLS; CELL DIFFERENTIATION; COCULTURE TECHNIQUES; HT29 CELLS; HUMANS; METHOTREXATE; TIME FACTORS;

EID: 77952292395     PISSN: 10568719     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vascn.2010.02.004     Document Type: Article

References (27)

1. Artursson P., Karlsson J. Correlation between oral-drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochemical and Biophysical Research Communications 1991, 175:880-885.
2. Artursson P., Palm K., Luthman K. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Advanced Drug Delivery Reviews 2001, 46:27-43.
3. Banan A., Farhadi A., Fields J.Z., Mutlu E., Zhang L., Keshavarzian A. Evidence that nuclear factor-kappa B activation is critical in oxidant-induced disruption of the microtubule cytoskeleton and barrier integrity and that its inactivation is essential in epidermal growth factor-mediated protection of the monolayers of intestinal epithelia. Journal of Pharmacology and Experimental Therapeutics 2003, 306:13-28.
4. Behrens I., Stenberg P., Artursson P., Kissel T. Transport of lipophilic drug molecules in a new mucus-secreting cell culture model based on HT29-MTX cells. Pharmaceutical Research 2001, 18:1138-1145.
5. Chen X.M., Kitts D.D. Determining conditions for nitric oxide synthesis in Caco-2 cells using Taguchi and factorial experimental designs. Analytical Biochemistry 2008, 381:185-192.
6. Han X.N., Fink M.P., Delude R.L. Proinflammatory cytokines cause no center dot-dependent and -independent changes in expression and localization of tight junction proteins in intestinal epithelial cells. Shock 2003, 19:229-237.
7. Hidalgo I.J. Cultured intestinal epithelial cell models in pharmaceutical biotechnology. Models for assessing drug absorption and metabolism 1996, 35-50. Plenum Press, New York. R.T. Borchardt, P.L. Smith, G. Wilson (Eds.).
8. Hilgendorf C., Spahn-Langguth H., Regardh C.G., Lipka E., Amidon G.L., Langguth P. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: Permeabilities via diffusion, inside- and outside-directed carrier-mediated transport. Journal of Pharmaceutical Sciences 2000, 89:63-75.
9. Hilgers A.R., Conradi R.A., Burton P.S. Caco-2 cell monolayers as a model for drug transport across the intestinal-mucosa. Pharmaceutical Research 1990, 7:902-910.
10. Lesuffleur T., Barbat A., Luccioni C., Beaumatin J., Clair M., Kornowski A., et al. Dihydrofolate reductase gene amplification-associated shift of differentiation in methotrexate-adapted HT-29 cells. Journal of Cell Biology 1991, 115:1409-1418.
11. Mahler G.J., Shuler M.L., Glahn R.P. Characterization of Caco-2 and HT29-MTX cocultures in an in vitro digestion/cell culture model used to predict iron bioavailability. The Journal of Nutritional Biochemistry 2009, 20:494-502.
12. Mahler G.J., Esch M.B., Glahn R.P., Shuler M.L. Characterization of a gastrointestinal tract microscale cell culture analog used to predict drug toxicity. Biotechnology and Bioengineering 2009, 104:193-205.
13. Meaney C., O'Driscoll C. Mucus as a barrier to the permeability of hydrophilic and lipophilic compounds in the absence and presence of sodium taurocholate micellar systems using cell culture models. European Journal of Pharmaceutical Sciences 1999, 8:167-175.
14. Narayanan B.A., Narayanan N.K., Simi B., Reddy B.S. Modulation of inducible nitric oxide synthase and related proinflammatory genes by the omega-3 fatty acid docosahexaenoic acid in human colon cancer cells. Cancer Research 2003, 63:972-979.
15. Nollevaux G., Deville C., El Moualij B., Zorzi W., Deloyer P., Schneider Y.J., et al. Development of a serum-free co-culture of human intestinal epithelium cell-lines (Caco-2/HT29-5M21). Bmc Cell Biology 2006, 7:20.
16. Pinto M., Robineleon S., Appay M.D., Kedinger M., Triadou N., Dussaulx E., et al. Enterocyte-like differentiation and polarization of the human-colon carcinoma cell-line Caco-2 in culture. Biology of the Cell 1983, 47:323-330.
17. Robinson T.J., Borror C.M., Myers R.H. Robust parameter design: A review. Quality and Reliability Engineering International 2004, 2:81-101.
18. Sambuy Y., Angelis I., Ranaldi G., Scarino M.L., Stammati A., Zucco F. The Caco-2 cell line as a model of the intestinal barrier: Influence of cell and culture-related factors on Caco-2 cell functional characteristics. Cell Biology and Toxicology 2005, 21:1-26.
19. Sappington P.L., Fink M.E., Yang R.K., Delude R.L., Fink M.P. Ethyl pyruvate provides durable protection against inflammation-induced intestinal epithelial barrier dysfunction. Shock 2003, 20:521-528.
20. Shah P., Jogani V., Bagchi T., Misra A. Role of Caco-2 cell monolayers in prediction of intestinal drug absorption. Biotechnology Progress 2006, 22:186-198.
21. Unno N., Menconi M.J., Smith M., Fink M.P. Nitric-oxide mediates interferon-gamma-induced hyperpermeability in cultured human intestinal epithelial monolayers. Critical Care Medicine 1995, 23:1170-1176.
22. Walter E., Janich S., Roessler B.J., Hilfinger J.M., Amidon G.L. HT29-MTX/Caco-2 cocultures as an in vitro model for the intestinal epithelium: In vitro in vivo correlation with permeability data from rats and humans. Journal of Pharmaceutical Sciences 1996, 85:1070-1076.
23. Wikman A., Karlsson J., Carlstedt I., Artursson P. A drug absorption-model based on the mucus layer producing human intestinal goblet cell-line Ht29-H. Pharmaceutical Research 1993, 10:843-852.
24. Wikman-Larhed A., Artursson P. Cocultures of human intestinal goblet (Ht29-H) and absorptive (Caco-2) cells for studies of drug and peptide absorption. European Journal of Pharmaceutical Sciences 1995, 3:171-183.
25. Yang W.H., Tarng Y.S. Design optimization of cutting parameters for turning operations based on the Taguchi method. Journal of Materials Processing Technology 1998, 84:122-129.
26. Yasotha K., Aroua M.K., Ramachandran K.B., Tan I.K.P. Recovery of medium-chain-length polyhydroxyalkanoates (PHAs) through enzymatic digestion treatments and ultrafiltration. Biochemical Engineering Journal 2006, 30:260-268.
27. Zakeri-Milani P., Barzegar-Jalali M., Azimi M., Valizadeh H. Biopharmaceutical classification of drugs using intrinsic dissolution rate (IDR) and rat intestinal permeability. European Journal of Pharmaceutics and Biopharmaceutics 2009, 73:102-106.